Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Phase 1a/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression
This is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamic…
Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more
Estimated
~$10 – $8,750
Context Therapeutics Inc.NCT06756035
Phase 2
A Single Arm Phase 2 Study of Y-90 SIRT in Combination With Durvalumab (MEDI 4736) and Gemcitabine/Cisplatin in Locally Advanced, Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
This trial is designed to study a combination of interventions (chemotherapy, immunotherapy, and radiation) as a potential new treatment for bile duct cancer t…
Bile Duct CancerCholangiocarcinomaCholangiocarcinoma Non-resectable+2 more
Estimated
~$10 – $6,250
Beth Israel Deaconess Medical CenterNCT05655949